https://www.selleckchem.com/pr....oducts/xl413-bms-863
The purpose of this study is to investigate the effects of agomelatine on anxious symptoms and functional impairment in a pooled dataset from randomized placebo-controlled trials for generalized anxiety disorder (GAD). Data from three randomized, placebo-controlled trials that evaluated the efficacy of agomelatine 25-50mg were pooled. The short-term (12weeks) efficacy of agomelatine was assessed in regards to (1) anxious symptoms using the Hamilton Anxiety Scale (HAM-A), and (2) functional impairment using the Sheehan Disabilit
Like
Comment
Share
